ijms-logo

Journal Browser

Journal Browser

Synthesis and Structural Studies of Potential Anticancer Drugs

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pharmacology".

Deadline for manuscript submissions: 20 August 2026 | Viewed by 1663

Special Issue Editor


E-Mail Website
Guest Editor
Department of Organic Chemistry, Faculty of Chemistry, University of Gdańsk, Gdańsk, Poland
Interests: carbohydrates; synthesis and analysis of sugar derivatives; vancomycin and its derivatives; sugar hydrazides; cationic sugar compounds; biological activity of sugar derivatives
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,                

Cancer is defined as a disease in which cells begin to grow in an uncontrolled way and spread to other parts of the body. There are over 100 known varieties of cancer, and their names are usually derived from the organ or tissue in which they form. This number of varieties makes their diagnosis and treatment much more difficult. Cancer is one of the most deadly diseases in the world, and the forecasts are not optimistic. It is estimated that in 2050, the number of cancer cases worldwide will increase to 33 million (an increase of over 60% compared to 2022) and the number of cancer-related deaths will reach over 18 million, which will be almost a 90% increase compared to 2022. This state of affairs means that many research centers are conducting intensive work on better diagnostics, allowing for earlier detection of the disease, and on new, more effective therapies. One of the important elements of new therapies are new drugs that would be characterized by greater effectiveness and selectivity, and on the other hand, lower toxicity in relation to healthy cells.              

In this Special Issue “Synthesis and Structural Studies of Potential Anticancer Drugs”,  we would like to focus on the synthesis, structural studies, and biological activity of potential anticancer drugs. We would like to gather in one place new valuable articles contributing to the synthesis of new compounds with anticancer activity, and studies of their structure using spectroscopic, X-ray, and computational methods. An important element is also the possible dependencies of anticancer activity–structure. Review articles on these topics will also provide an important complementary element. 

Prof. Dr. Janusz Madaj
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • medicinal chemistry
  • drug discovery
  • design and synthesis of bioactive compounds
  • molecular modeling
  • X-ray crystallography
  • structure–activity relationships
  • structure-based drug design

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

35 pages, 4216 KB  
Review
Anticancer Activity of Schiff Base Metal Complexes Against MCF-7 Breast Cancer Cell Line
by Justyna Samaszko-Fiertek, Barbara Dmochowska and Janusz Madaj
Int. J. Mol. Sci. 2026, 27(2), 678; https://doi.org/10.3390/ijms27020678 - 9 Jan 2026
Cited by 1 | Viewed by 1351
Abstract
According to the World Health Organization, breast cancer is the cancer that affects the largest number of people each year, especially women. Millions of women are diagnosed with it each year, and hundreds of thousands die from it. Research into new types of [...] Read more.
According to the World Health Organization, breast cancer is the cancer that affects the largest number of people each year, especially women. Millions of women are diagnosed with it each year, and hundreds of thousands die from it. Research into new types of drugs, including metal complexes, including those containing tetradentate Schiff bases as ligands, offers a chance to reduce this number. Various cell lines are being used to test their effectiveness in cancer therapy, with the MCF-7 cancer cell line being the most commonly used. A literature search was conducted in four major databases: PubMed, SciELO. The Boolean operator “and” was used to refine the search strategy, combining the terms Schiff base, breast cancer, MCF-7 and metal complexes. Studies published between 2020 and 2025 investigating the cytotoxic activity of metal complexes with Schiff base ligands on the MCF-7 breast cancer cell line were included in the analysis. Articles were considered eligible if they were written in English. As a result of the database search, 37 scientific articles were selected and divided into three groups based on the ligand structure. The largest group of articles described the synthesis, structure, and anticancer activity of metal complexes with ligands based on the salicylaldehyde structure. These were included in the first group of complexes described. The second, extremely interesting and promising group of compounds consisted of metal complexes with ligands containing a sulfur atom. The last group included metal complexes with Schiff base ligands that were not included in the two previously mentioned groups. As indicated by the research results contained in the reviewed articles, Schiff base metal complexes constitute an interesting group of compounds characterized by a range of activities, including anticancer activity, which may in the future be used in anticancer therapy. They may also represent a cheaper and more effective alternative to platinum-based drugs. Full article
(This article belongs to the Special Issue Synthesis and Structural Studies of Potential Anticancer Drugs)
Show Figures

Figure 1

Back to TopTop